Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cystic Fibrosis: Pathogenesis

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

Cystic Fibrosis: Management

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Hand in glove: New imaging techniques and airway endoscopy.

Paediatric respiratory reviews·2026

Same author

CFTR modulators: eligibility, pseudomonas burden and justifying life-long therapy.

Paediatric respiratory reviews·2026

Same author

What was that you said?

Paediatric respiratory reviews·2026

Same author

Reframing and clarifying melatonin use in paediatric sleep care.

Paediatric respiratory reviews·2026

Same author

Editorial: Difficult to treat asthma in vulnerable populations.

Paediatric respiratory reviews·2025

Same author

Chalazion and hordeolum in paediatric patients with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor.

Paediatric respiratory reviews·2025

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Non-cystic fibrosis bronchiectasis.

Haya Al Subie¹, Dominic A Fitzgerald

¹Department of Respiratory Medicine, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.

Journal of Paediatrics and Child Health

|November 3, 2010

Summary

This summary is machine-generated.

Non-cystic fibrosis bronchiectasis remains a significant health issue, particularly in Indigenous Australian and New Zealand children. Early diagnosis and airway clearance are crucial for managing this chronic respiratory condition.

More Related Videos

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jun 7, 2026

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections

Published on: May 8, 2017

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Area of Science:

Pediatrics
Respiratory Medicine
Public Health

Background:

Non-cystic fibrosis bronchiectasis (NCFB) prevalence is high in Indigenous Australian and New Zealand populations.
Early childhood pneumonia and immunodeficiency are key etiological factors in NCFB.
NCFB presents a diagnostic and management challenge in pediatric populations.

Purpose of the Study:

To review the clinical presentation, diagnostic approaches, and management strategies for NCFB in children.
To update general pediatricians on current knowledge regarding NCFB.
To highlight the specific challenges of NCFB in Indigenous communities.

Main Methods:

Literature review focusing on NCFB in children.
Analysis of etiological factors, diagnostic tools, and treatment modalities.
Synthesis of information for a pediatric audience.

Main Results:

High-resolution computed tomography (HRCT) is essential for diagnosing suspected NCFB in children with chronic wet cough.
Management focuses on airway secretion clearance and treating pulmonary exacerbations.
Understanding underlying conditions like primary ciliary dyskinesia is vital.

Conclusions:

NCFB requires prompt recognition and management in pediatric practice.
Effective management involves proactive airway clearance and exacerbation treatment.
Addressing NCFB in Indigenous communities necessitates culturally sensitive approaches and further research.